Trisubstituted naphthylalkylamides for disorders of the melatoninergic system
US5591775A · kind A · utility
5Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 1994 |
| Grant date | Jan 7, 1997 |
| Priority date | — |
| Expiry date | Dec 6, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to a compound selected from those of formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined herein for use in the treatment of a disorder of the melatoninergic system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.